Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.885 USD | +7.10% | 0.00% | -19.36% |
05-09 | Transcript : Xeris Biopharma Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Earnings Flash (XERS) XERIS BIOPHARMA HOLDINGS Reports Q1 Revenue $40.6M, vs. Street Est of $41.8M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.36% | 261M | |
+29.42% | 684B | |
+30.34% | 568B | |
-3.96% | 361B | |
+17.83% | 329B | |
+4.03% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+6.86% | 166B |
- Stock Market
- Equities
- XERS Stock
- News Xeris Biopharma Holdings, Inc.
- SVB Securities Trims Xeris Biopharma Price Target to $5 From $6, Maintains Outperform Rating